NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Medifast Inc. (LSE: 0K05)
0K05 Technical Analysis
5
As on 16th May 2025 0K05 STOCK Price closed @ 13.74 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 33.73 & Strong Sell for SHORT-TERM with Stoploss of 61.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0K05STOCK Price
Open | 13.43 | Change | Price | % |
High | 13.85 | 1 Day | 0.94 | 7.34 |
Low | 13.43 | 1 Week | 0.76 | 5.86 |
Close | 13.74 | 1 Month | 0.45 | 3.39 |
Volume | 185 | 1 Year | -52.48 | -79.25 |
52 Week High 75.67 | 52 Week Low 11.89 |
LSE UK Most Active Stocks
MSMN | 0.05 | -16.67% |
ENET | 0.03 | 50.00% |
UKOG | 0.01 | 0.00% |
EME | 0.03 | 0.00% |
WBI | 0.05 | 25.00% |
CPX | 0.17 | 6.25% |
MIRI | 0.02 | 100.00% |
DEMG | 0.02 | -50.00% |
VRS | 0.03 | 0.00% |
SMDS | 582.50 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
0K05 Daily Charts |
0K05 Intraday Charts |
Whats New @ Bazaartrend |
0K05 Free Analysis |
|
0K05 Important Levels Intraday
RESISTANCE | 14.55 |
RESISTANCE | 14.29 |
RESISTANCE | 14.13 |
RESISTANCE | 13.97 |
SUPPORT | 13.51 |
SUPPORT | 13.35 |
SUPPORT | 13.19 |
SUPPORT | 12.93 |
0K05 Forecast May 2025
4th UP Forecast | 49.93 |
3rd UP Forecast | 38.32 |
2nd UP Forecast | 31.15 |
1st UP Forecast | 23.98 |
1st DOWN Forecast | 3.5 |
2nd DOWN Forecast | -3.67 |
3rd DOWN Forecast | -10.84 |
4th DOWN Forecast | -22.45 |
0K05 Weekly Forecast
4th UP Forecast | 38.17 |
3rd UP Forecast | 30.34 |
2nd UP Forecast | 25.49 |
1st UP Forecast | 20.65 |
1st DOWN Forecast | 6.83 |
2nd DOWN Forecast | 1.99 |
3rd DOWN Forecast | -2.86 |
4th DOWN Forecast | -10.69 |
0K05 Forecast2025
4th UP Forecast | 137.41 |
3rd UP Forecast | 97.75 |
2nd UP Forecast | 73.23 |
1st UP Forecast | 48.72 |
1st DOWN Forecast | -21.24 |
2nd DOWN Forecast | -45.75 |
3rd DOWN Forecast | -70.27 |
4th DOWN Forecast | -109.93 |
Medifast Inc. ( LSE UK Symbol : 0K05 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0K05 Other Details
Segment | EQ | |
Market Capital | 2290371584.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
0K05 Address
![]() |
0K05 Latest News
0K05 Business Profile
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and its franchisee system. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. Address: 100 International Drive, Baltimore, MD, United States, 21202
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service